GO
 
COOKIES - Este website usa cookies próprios e de terceiros para lhe fornecer a melhor experiência possível. Ao clicar em "Aceito" ou percorrer esta página, você aceita cookies.
ACEITO LER A POLÍTICA COMPLETA
BMJ - Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study

BMJ - Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study

British Medical JournalOf 4297 patients admitted to hospital with covid-19, 3627 (84.4%) received prophylactic anticoagulation within 24 hours of admission. More than 99% (n=3600) of treated patients received subcutaneous heparin or enoxaparin....
ECDC - Risk assessment: SARS-CoV-2 - increased circulation of variants of concern and vaccine rollout in the EU/EEA, 14th update

ECDC - Risk assessment: SARS-CoV-2 - increased circulation of variants of concern and vaccine rollout in the EU/EEA, 14th update

European Centre for Disease Prevention and ControlSeveral EU/EEA countries have observed a decline in the overall incidence of SARS-CoV-2 in recent weeks, most probably due to the impact of tightened non-pharmaceutical interventions (NPIs). 
ECDC - Using face masks in the community: first update - Effectiveness in reducing transmission of COVID-19

ECDC - Using face masks in the community: first update - Effectiveness in reducing transmission of COVID-19

European Centre for Disease Prevention and ControlThe role of face masks in the control and prevention of COVID-19 remains an issue of debate. Prior to COVID-19, most studies assessing the effectiveness of face masks as a protective measure in...
ECDC - Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA

ECDC - Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA

European Centre for Disease Prevention and ControlOn 19 January 2021 the European Commission set out actions to step up the response against the COVID-19 pandemic and accelerate the rollout of vaccination campaigns across the EU, with the aim to...
ECDC - Integrated COVID-19 response in the vaccination era

ECDC - Integrated COVID-19 response in the vaccination era

European Centre for Disease Prevention and ControlDue to the emergence of more transmissible variants of SARS-CoV-2, it will be necessary to strengthen and maintain response measures in the coming months to avoid further rises in mortality, even...
JAMA - Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children

JAMA - Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children

JAMA NETWORKMultisystem inflammatory syndrome in children (MIS-C) is the most severe pediatric disease associated with severe acute respiratory syndrome coronavirus 2 infection, potentially life-threatening, but the optimal therapeutic strategy...
DGS - Campanha de Vacinação contra a COVID-19 COVID-19 Vaccine AstraZeneca®

DGS - Campanha de Vacinação contra a COVID-19 COVID-19 Vaccine AstraZeneca®

Norma da Direção-Geral da SaúdeA vacinação contra a COVID-19 com COVID-19 Vaccine AstraZeneca® deve respeitar as regras definidas para esta Campanha de Vacinação, de acordo com a Norma 002/2021 e as regras gerais de vacinação, constantes da Norma...
CDC - Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS

CDC - Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS

Centers for Disease Control and PreventionUniversal masking is recommended to slow the spread of COVID-19. Cloth masks and medical procedure masks substantially reduce exposure from infected wearers (source control) and reduce exposure of...
ECDC - Infection prevention and control and preparedness for COVID-19 in healthcare settings

ECDC - Infection prevention and control and preparedness for COVID-19 in healthcare settings

European Centre for Disease Prevention and ControlThis document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and...
DGS - COVID-19: Rastreio de Contactos

DGS - COVID-19: Rastreio de Contactos

Direção-Geral da Saúde

Norma para o rastreio de contactos COVID-19

BMJ - Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

BMJ - Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

British Medical JournalThe coronavirus disease 2019 (covid-19) pandemic has led to profound worldwide health, economic, and social losses. As of October 2020, more than 40 million people have received a diagnosis of covid-19 and one million...
NEJM - Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19

NEJM - Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19

The New England Journal of MedicineThe duration of transmissibility of coronavirus disease 2019 (Covid-19) and the associated level of contagion have been uncertain. We cultured severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in...
AMP - Allergic Reactions to COVID-19 Vaccines: An Allergist’s Perspective

AMP - Allergic Reactions to COVID-19 Vaccines: An Allergist’s Perspective

Acta Médica PortuguesaThe COVID-19 vaccines approved so far for use in the European Union (EU) include those from Pfizer/BioNTech®, Moderna® and AstraZeneca®. Two severe cases of anaphylaxis that were resolved after treatment were reported on the...
JAMA - Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

JAMA - Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

JAMA NETWORKOn December 11, 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine, administered as 2 doses separated by 21...
NEJM - Maintaining Safety with SARS-CoV-2 Vaccines

NEJM - Maintaining Safety with SARS-CoV-2 Vaccines

The New England Journal of MedicineTo date, the development of mRNA vaccines for the prevention of infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a success story, with no serious concerns identified in...
124678910Último
Eventos
«junho de 2023»
segterquaquisexsábdom
2930311234
567891011
12131415161718
19202122232425
262728293012
3456789
Categorias

Categorias

Arquivo de Notícias

Arquivo